Browse studies

Find your next paid study

27,375 recruiting studies available now

An Open-label Phase 1 Study to Investigate PF-08046050 (SGN-CEACAM5C) in Adults With Advanced Solid Tumors

This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your bloo…

Colorectal NeoplasmsCarcinoma, Non-Small-Cell LungStomach Neoplasms+3 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Seagen, a wholly owned subsidiary of PfizerNCT06131840

Phase 1

Matched Related Donor Non-myeloablative Hematopoietic Cell Transplantation With Alemtuzumab, 400 cGy TBI, and Abatacept for Sickle Cell Disease and Beta-Thalassemia

This is a non-ablative (partial) stem cell transplant for patients with severe sickle cell disease or beta-thalassemia requiring red cell transfusions. The int…

Sickle Cell DiseaseBeta-thalassemia

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Heart, Lung, and Blood Institute (NHLBI)NCT07599176

Phase 1

A Dose-Escalation Study Evaluating the Safety and Tolerability of Artesunate in Participants With Idiopathic Pulmonary Fibrosis (SAFE-IPF)

Idiopathic Pulmonary Fibrosis (IPF) is a chronic progressive fibrotic lung disease resulting in increasing shortness of breath, cough, and low oxygen levels as…

Idiopathic Pulmonary Fibrosis

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Joseph C. WuNCT05988463

Observational

Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial

The purpose of this study is to determine the effect of a multidisciplinary intervention at care transitions for acute kidney injury survivors on patient-cente…

Acute Kidney Injury

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07670520

Phase 1

A Phase 1, First in Human, Open-Label Multicenter Study to Evaluate ALX2004, an Antibody Drug Conjugate Targeting EGFR in Participants With Advanced or Metastatic Select Solid Tumors

A Phase 1, First in Human, Open-Label Multicenter Study to Evaluate ALX2004, an Antibody Drug Conjugate Targeting EGFR in Participants with Advanced or Metasta…

NSCLC (Advanced Non-small Cell Lung Cancer)HNSCCCRC (Colorectal Cancer)+4 more

Estimated

~$150 – $4,200

Actual pay is set by the research site.

ALX Oncology Inc.NCT07085091

Phase 3

A Phase 3, Multicenter, Randomized, Open-label, Study Evaluating the Efficacy and Safety of Nanvuranlat in Patients With Previously Treated Advanced Biliary Tract Cancer

This study is designed to 1) select a dose regimen for continued development and 2) evaluate nanvuranlat versus Physicians Best Choice (PBC) (FOLFOX, FOLFIRI, …

Advanced Biliary Tract CancerBiliary Tract Cancer (BTC)

Estimated

~$50 – $2,100

Actual pay is set by the research site.

J-Pharma Co., Ltd.NCT07265674

Observational

Improving Health Among Disadvantaged Girls to Slow Pubertal Onset and Reduce Long-term Health Risks

This study is testing whether improving health in girls during the prepubertal period may slow the onset of puberty. This study will focus on prepubertal girls…

Overweight/ObesityPubertyHealth Behavior+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of WashingtonNCT07460544

Observational

Sleep-specific DBS Therapy in Parkinson's Disease

Sleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological dis…

Deep Brain StimulationParkinson's Disease and ParkinsonismDystonia

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MinnesotaNCT05962489

Phase 1

Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder

The goal of this clinical trial is to evaluate whether a single dose of psilocybin is feasible and safe for adults with opioid use disorder (OUD) who are recov…

Pain ManagementPostoperative Pain

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Trent EmerickNCT07406828

Phase 3

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Switching to a Regimen of Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir Twice-Yearly in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens

The goal of this clinical study is to compare how effective a long-acting treatment of injectable combination of lenacapavir (LEN), teropavimab (TAB), and zinl…

HIV-1-infection

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Gilead SciencesNCT07683000

Phase 2

An Adaptive Two-part Randomized, Double Blind, Placebo-controlled Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Emraclidine in Participants With Schizophrenia

Schizophrenia is a common and severe psychiatric illness characterized by extreme disturbances of cognition and thought, affecting language, perception and sen…

Schizophrenia

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT07145918

Gaining Insights Into Patient Involvement Patterns and Trends in Participation in Lymphoma Clinical Trials

Participation in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affec…

Lymphoma

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Power Life Sciences Inc.NCT06070246